Where should I publish my paper?
Paste your title, abstract or keywords. The finder matches them to research topics and suggests ranked journals that publish most on those topics.
Journals for “Cancer Cells and Metastasis”
Suggested journals
Topic match is relative to the best match in this search (100% = best). Under each journal, "Publishes on" shows which of the matched topics it publishes and what share of its recent papers they make up. Fees are shown only where DOAJ records them; "Not recorded" does not mean the journal is free.
| # | Journal | Topic match | ITS Journal Score | Global rank | Papers 2021–2025 | Open access | Fee (APC) | Compare |
|---|---|---|---|---|---|---|---|---|
| 1 | Organoids Multidisciplinary Digital Publishing Institute · DOAJ Publishes on: Cancer Cells and Metastasis (20%) | 100% | 53.4 | #17,149 | 86 | 100% | 1,000 CHF | |
| 2 | Cancer and Metastasis Reviews Springer Science+Business Media · The Netherlands Publishes on: Cancer Cells and Metastasis (16%) | 80% | 86.8 | #571 | 364 | 67% | Not recorded | |
| 3 | Cellular Oncology Springer Nature · The Netherlands · DOAJ Publishes on: Cancer Cells and Metastasis (16%) | 81% | 75.7 | #3,802 | 563 | 100% | US$2,380 | |
| 4 | Cancer Science Wiley · Japan · DOAJ Publishes on: Cancer Cells and Metastasis (13%) | 64% | 82.6 | #1,334 | 2,031 | 100% | Not recorded | |
| 5 | Computational and Systems Oncology Wiley · United States · DOAJ Publishes on: Cancer Cells and Metastasis (18%) | 89% | 36.0 | #32,831 | 64 | 100% | US$3,520 | |
| 6 | South Russian Journal of Cancer ANO "Perspective of oncology" · Russia · DOAJ Publishes on: Cancer Cells and Metastasis (18%) | 87% | 39.5 | #28,908 | 164 | 100% | Not recorded | |
| 7 | Organoid The Organoid Society · South Korea · DOAJ Publishes on: Cancer Cells and Metastasis (18%) | 86% | 40.4 | #27,941 | 82 | 100% | Not recorded | |
| 8 | Cell Proliferation Wiley · United Kingdom · DOAJ Publishes on: Cancer Cells and Metastasis (13%) | 63% | 82.4 | #1,383 | 1,078 | 100% | 3,100 EUR | |
| 9 | Egyptian Journal of Pathology Lippincott Williams & Wilkins · Egypt Publishes on: Cancer Cells and Metastasis (18%) | 90% | 25.1 | #46,707 | 98 | 86% | Not recorded | |
| 10 | Journal of Experimental & Clinical Cancer Research BioMed Central · United Kingdom · DOAJ Publishes on: Cancer Cells and Metastasis (11%) | 54% | 90.1 | #243 | 1,812 | 100% | Not recorded | |
| 11 | Advances in Cancer Biology - Metastasis Elsevier BV · The Netherlands · DOAJ Publishes on: Cancer Cells and Metastasis (14%) | 69% | 59.2 | #13,378 | 158 | 100% | US$3,080 | |
| 12 | Neoplasia Elsevier BV · United Kingdom · DOAJ Publishes on: Cancer Cells and Metastasis (11%) | 54% | 80.5 | #2,004 | 569 | 100% | US$3,790 | |
| 13 | Cancer Drug Resistance United States Publishes on: Cancer Cells and Metastasis (12%) | 57% | 72.7 | #5,284 | 309 | 100% | Not recorded | |
| 14 | Molecular Oncology Elsevier BV · The Netherlands · DOAJ Publishes on: Cancer Cells and Metastasis (11%) | 53% | 78.4 | #2,742 | 1,189 | 100% | US$4,730 | |
| 15 | Cellular and Molecular Gastroenterology and Hepatology Elsevier BV · The Netherlands · DOAJ Publishes on: Cancer Cells and Metastasis (11%) | 52% | 78.0 | #2,890 | 1,069 | 100% | US$3,770 | |
| 16 | Cancers Multidisciplinary Digital Publishing Institute · Switzerland Publishes on: Cancer Cells and Metastasis (10%) | 47% | 87.0 | #550 | 26,937 | 100% | Not recorded | |
| 17 | Molecular Cancer BioMed Central · United Kingdom · DOAJ Publishes on: Cancer Cells and Metastasis (9%) | 43% | 94.6 | #51 | 1,227 | 100% | 4,390 EUR | |
| 18 | Cell Communication and Signaling BioMed Central · United Kingdom · DOAJ Publishes on: Cancer Cells and Metastasis (9%) | 45% | 87.3 | #510 | 1,919 | 100% | 2,990 EUR | |
| 19 | Journal of Cancer Biology Publishes on: Cancer Cells and Metastasis (14%) | 68% | 43.1 | #25,157 | 69 | 45% | Not recorded | |
| 20 | Journal of Mammary Gland Biology and Neoplasia Springer Science+Business Media · United States Publishes on: Cancer Cells and Metastasis (11%) | 52% | 68.5 | #7,683 | 115 | 88% | Not recorded | |
| 21 | Clinical & Experimental Metastasis Springer Science+Business Media · The Netherlands Publishes on: Cancer Cells and Metastasis (10%) | 47% | 76.3 | #3,579 | 316 | 55% | Not recorded | |
| 22 | Translational Oncology Elsevier BV · United States · DOAJ Publishes on: Cancer Cells and Metastasis (9%) | 45% | 78.9 | #2,524 | 1,608 | 100% | US$3,880 | |
| 23 | Molecular Cancer Research American Association for Cancer Research · United States Publishes on: Cancer Cells and Metastasis (9%) | 46% | 77.1 | #3,225 | 727 | 64% | Not recorded | |
| 24 | Oncogenesis Springer Nature · United States · DOAJ Publishes on: Cancer Cells and Metastasis (10%) | 47% | 74.8 | #4,197 | 304 | 100% | 3,590 EUR | |
| 25 | Nature reviews. Cancer Nature Portfolio · United Kingdom Publishes on: Cancer Cells and Metastasis (7%) | 36% | 95.0 | #43 | 575 | 25% | Not recorded | |
| 26 | Critical Reviews™ in Oncogenesis Begell House · United States Publishes on: Cancer Cells and Metastasis (11%) | 53% | 61.0 | #12,277 | 212 | 37% | Not recorded | |
| 27 | Journal of Cancer Metastasis and Treatment United States Publishes on: Cancer Cells and Metastasis (11%) | 54% | 58.7 | #13,735 | 222 | 100% | Not recorded | |
| 28 | Trends in cancer Elsevier BV · United States Publishes on: Cancer Cells and Metastasis (8%) | 39% | 86.0 | #674 | 667 | 50% | Not recorded | |
| 29 | Experimental Oncology Ukraine Publishes on: Cancer Cells and Metastasis (11%) | 54% | 56.3 | #15,245 | 313 | 91% | Not recorded | |
| 30 | Journal of Cancer Research and Clinical Oncology Springer Science+Business Media · Germany · DOAJ Publishes on: Cancer Cells and Metastasis (8%) | 40% | 82.5 | #1,369 | 2,893 | 100% | Not recorded |
Before you submit
Use this list as a shortlist, not a decision. For each journal, read its aims and scope and a few recent articles, check its peer-review and fee policy on its own website, and confirm any indexing (Scopus, Web of Science, PubMed) with the indexer itself. Be careful with journals that promise very fast acceptance or that contact you by email asking for papers.
How the ITS Journal Score works
One formula applies to every ranked journal, using open data from OpenAlex: 45% citation impact, 35% h-index and 20% size (papers published 2021–2025). Citation impact is the smaller of the journal's two-year mean citedness and its five-year citations per paper, so a journal whose output collapsed cannot jump to the top on old citations. Each part is half a percentile and half a log-scaled value, so the very top is still separated. Growth and open-access share are shown separately and are not part of the score.
A journal is ranked only if it published at least 50 papers in 2021–2025 and was active in at least five of the last six years. Field rankings compare a journal only with journals in the same field; the field is the OpenAlex field with most of the journal's recent papers, or "Multidisciplinary" when no field has 30% of them.
What this is not: the ITS Journal Score is not a Journal Impact Factor, CiteScore or SJR, and this site does not say whether a journal is indexed in Scopus, Web of Science or PubMed. Always confirm aims and scope, indexing, peer review and fees on the journal's own website before you submit.